Status:
NOT_YET_RECRUITING
AI-enhanced Imaging Analysis to Predict Post-EVAR
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Aortic Aneurysm
Eligibility:
All Genders
18+ years
Brief Summary
Abdominal aortic aneurysm (AAA), defined as a focal dilatation of the aorta, is a life-threatening condition and has become a serious public health challenge worldwide, associated with high rates of m...
Eligibility Criteria
Inclusion
- Pre-operative CTA should be performed maximum 6 months before the intervention,
- At least one post-operative CTA should be performed between 1 month and 12 months following the intervention,
- CTA needs to be contrast-enhanced with at least injection at arterial and/or portal time,
- CTA should have a spacing no more than 1 mm.
Exclusion
- age \< 18 years, - patients with syndromic AAA,
- patients who underwent open repair or complex EVAR (adjunctive sac embolization procedure, chimney/snorkel or fenestrated-branched endografts),
- ruptured AAA,
- previous history of AAA repair,
- patients for whom one pre-operative and at least one post-operative CTA (within 1-year) are not available.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06592105
Start Date
January 1 2025
End Date
January 1 2028
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU NICE
Nice, ALPES MARITIMES, France, 0600